Literature DB >> 14730046

Vascular dilatation in the pelvis: identification with CT and MR imaging.

Shigeaki Umeoka1, Takashi Koyama, Kaori Togashi, Hisato Kobayashi, Keizo Akuta.   

Abstract

Focal or diffuse dilatation of pelvic vessels is observed occasionally on computed tomographic or magnetic resonance images. Two major mechanisms may account for dilatation. The first mechanism is development of collateral channels as a result of venous obstruction or stenosis. Symptoms associated with vessel dilatation vary according to the level of obstruction. Portal hypertension also may result in the formation of numerous collateral vessels. In addition, left renal venous compression between the aorta and the superior mesenteric artery, which results in blood flow from the left renal vein toward the left gonadal vein, causes a variety of symptoms. The second major mechanism for dilatation is increased blood flow through collateral vessels associated with a neoplasm or vascular lesion. Hypervascular pelvic tumors such as uterine leiomyomas, gestational trophoblastic neoplasms, ovarian solid tumors, and mesenteric tumors may be associated with a marked increase in the number of draining vessels. The assessment of such vessels can assist in identification of tumor origins. Visual recognition of abnormal pelvic vasculature and abnormal hemodynamics is clinically important because it helps to improve diagnosis of a wide variety of pelvic and systemic diseases. Moreover, recognition of abnormal hemodynamics facilitates understanding of the physiology of such conditions. Recognition of the pattern of collateral channels also assists in identification of the level of narrowing even when the level is not readily apparent and is dependent on postural position. Copyright RSNA, 2004

Entities:  

Mesh:

Year:  2004        PMID: 14730046     DOI: 10.1148/rg.241035061

Source DB:  PubMed          Journal:  Radiographics        ISSN: 0271-5333            Impact factor:   5.333


  14 in total

1.  Association of left renal vein variations and pelvic varices in abdominal MDCT.

Authors:  Zafer Koc; Serife Ulusan; Levent Oguzkurt
Journal:  Eur Radiol       Date:  2006-10-13       Impact factor: 5.315

2.  Pelvic congestion syndrome: diagnosis and treatment.

Authors:  Elizabeth A Ignacio; Ruchika Dua; Shawn Sarin; Amy Soltes Harper; Douglas Yim; Vivek Mathur; Anthony C Venbrux
Journal:  Semin Intervent Radiol       Date:  2008-12       Impact factor: 1.513

3.  Multi-detector row computed tomography findings of pelvic congestion syndrome caused by dilated ovarian veins.

Authors:  Suat Eren
Journal:  Eurasian J Med       Date:  2010-12

Review 4.  Pelvic incidentalomas.

Authors:  R M Gore; G M Newmark; K H Thakrar; U K Mehta; J W Berlin
Journal:  Cancer Imaging       Date:  2010-10-04       Impact factor: 3.909

Review 5.  In pursuit of new anti-angiogenic therapies for cancer treatment.

Authors:  Jun Cai; Song Han; Ruan Qing; Daiqing Liao; Brian Law; Michael E Boulton
Journal:  Front Biosci (Landmark Ed)       Date:  2011-01-01

6.  Female pelvic congestion syndrome: how can CT and MRI help in the management decision?

Authors:  Ahmed M Osman; Ahmed Mordi; Rasha Khattab
Journal:  Br J Radiol       Date:  2020-12-04       Impact factor: 3.039

Review 7.  Management of Patients when Superficial Venous Disease Arises from Pelvic Escape Points.

Authors:  Rakesh S Ahuja; Tushar Garg; Deepak Sudheendra
Journal:  Semin Intervent Radiol       Date:  2021-06-03       Impact factor: 1.780

Review 8.  Gestational trophoblastic disease: a multimodality imaging approach with impact on diagnosis and management.

Authors:  Sunita Dhanda; Subhash Ramani; Meenkashi Thakur
Journal:  Radiol Res Pract       Date:  2014-07-13

9.  Imaging in spinal posterior epidural space lesions: A pictorial essay.

Authors:  Foram B Gala; Yashant Aswani
Journal:  Indian J Radiol Imaging       Date:  2016 Jul-Sep

10.  Unique nutcracker phenomenon involving the right renal artery and portal venous system.

Authors:  Maximilian Stephens; Sarah Kate Ryan; Roger Livsey
Journal:  Case Rep Vasc Med       Date:  2014-07-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.